Cargando…

Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy

As Zika virus (ZIKV) emerges into Dengue virus (DENV)-endemic areas, cases of ZIKV infection in DENV-immune pregnant women may rise. Here we show that prior DENV immunity affects maternal and fetal ZIKV infection in pregnancy using sequential DENV and ZIKV infection models. Fetuses in ZIKV-infected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regla-Nava, Jose Angel, Elong Ngono, Annie, Viramontes, Karla M., Huynh, Anh-Thy, Wang, Ying-Ting, Nguyen, Anh-Viet T., Salgado, Rebecca, Mamidi, Anila, Kim, Kenneth, Diamond, Michael S., Shresta, Sujan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072705/ https://www.ncbi.nlm.nih.gov/pubmed/30072692 http://dx.doi.org/10.1038/s41467-018-05458-0

Ejemplares similares

Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge
por: Wen, Jinsheng, et al.
Publicado: (2017)

Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development
por: Elong Ngono, Annie, et al.
Publicado: (2019)

CD4(+) T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection
por: Wen, Jinsheng, et al.
Publicado: (2020)

Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice
por: Branche, Emilie, et al.
Publicado: (2019)

Detection of Zika virus in mouse mammary gland and breast milk
por: Regla-Nava, Jose Angel, et al.
Publicado: (2019)

Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand
por: Hattakam, Sararat, et al.
Publicado: (2021)

CD4(+) T cells promote humoral immunity and viral control during Zika virus infection
por: Elong Ngono, Annie, et al.
Publicado: (2019)

Correction: CD4(+) T cells promote humoral immunity and viral control during Zika virus infection
por: Elong Ngono, Annie, et al.
Publicado: (2019)

Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection
por: Elong Ngono, Annie, et al.
Publicado: (2016)

CD8(+) T cells mediate protection against Zika virus induced by an NS3-based vaccine
por: Elong Ngono, Annie, et al.
Publicado: (2020)

Investigation of the immunogenicity of Zika glycan loop
por: Henderson, Elizabeth A., et al.
Publicado: (2020)

A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity
por: Regla-Nava, Jose Angel, et al.
Publicado: (2022)

Development of Zika Virus Vaccines
por: Makhluf, Huda, et al.
Publicado: (2018)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Role of Complement in Dengue Virus Infection: Protection or Pathogenesis?
por: Shresta, Sujan
Publicado: (2012)

Deconvolution of pro- and antiviral genomic responses in Zika virus-infected and bystander macrophages
por: Carlin, Aaron F., et al.
Publicado: (2018)

A longitudinal systems immunologic investigation of acute Zika virus infection in an individual infected while traveling to Caracas, Venezuela
por: Carlin, Aaron F., et al.
Publicado: (2018)

Mouse Models to Study Dengue Virus Immunology and Pathogenesis
por: Zellweger, Raphaël M., et al.
Publicado: (2014)

Acute-phase Serum Cytokine Levels and Correlation with Clinical Outcomes in Children and Adults with Primary and Secondary Dengue Virus Infection in Myanmar between 2017 and 2019
por: Nwe, Khine Mya, et al.
Publicado: (2022)

The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis
por: Langerak, Thomas, et al.
Publicado: (2019)

Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
por: Salazar, Vanessa, et al.
Publicado: (2019)

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2016)

Serological Cross Reactivity between Zika and Dengue Viruses in Experimentally Infected Monkeys
por: Mani, Shailendra, et al.
Publicado: (2018)

Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology
por: Priyamvada, Lalita, et al.
Publicado: (2017)

Zika virus enhances dengue risk
por: York, Ashley
Publicado: (2020)

Chikungunya Virus and Zika Virus Expansion: An Imitation of Dengue Virus
por: Fong, I. W.
Publicado: (2017)

Dengue virus antibodies enhance Zika virus infection
por: Paul, Lauren M, et al.
Publicado: (2016)

The 8-bromobaicalein inhibited the replication of dengue, and Zika viruses and targeted the dengue polymerase
por: Boonyasuppayakorn, Siwaporn, et al.
Publicado: (2023)

Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection
por: Badolato‐Corrêa, Jessica, et al.
Publicado: (2017)

Japanese encephalitis virus–primed CD8(+) T cells prevent antibody-dependent enhancement of Zika virus pathogenesis
por: Chen, Dong, et al.
Publicado: (2020)

Tracking the Evolution of Dengue Virus Strains D2S10 and D2S20 by 454 Pyrosequencing
por: Makhluf, Huda, et al.
Publicado: (2013)

STAT2 Mediates Innate Immunity to Dengue Virus in the Absence of STAT1 via the Type I Interferon Receptor
por: Perry, Stuart T., et al.
Publicado: (2011)

SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus
por: Branche, Emilie, et al.
Publicado: (2022)

Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
por: Shiryaev, Sergey A., et al.
Publicado: (2017)

Zika virus oncolytic activity requires CD8(+) T cells and is boosted by immune checkpoint blockade
por: Nair, Sharmila, et al.
Publicado: (2021)

Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora’s box?
por: Gunawardana, Shannon A., et al.
Publicado: (2018)

Upregulation of HLA‐E by dengue and not Zika viruses
por: Drews, Elena, et al.
Publicado: (2018)

Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection
por: Pinto, Amelia K., et al.
Publicado: (2015)

Potential role of dengue virus, chikungunya virus and Zika virus in neurological diseases
por: Vieira, Marcelo Adriano da Cunha e Silva, et al.
Publicado: (2018)

Author Correction: The 8-bromobaicalein inhibited the replication of dengue, and Zika viruses and targeted the dengue polymerase
por: Boonyasuppayakorn, Siwaporn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b6rnirhjd1utsvoer4i111o6rg